Table 2.
Detailed characteristics of the 14 patients with PAS
| Patient no. | Age (years) | Gender | D-dimer level | Tumor location | Tumor staging | Enhanced CT value (HU) | ΔCT value (HU) | SUVmax | MTV | TLG | OS (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 57 | M | N | LPA | II | 66 | 21 | 7.2 | 26.8 | 114.2 | 3.0 |
| 2 | 33 | F | A | RPA | I | 67 | 26 | 8.0 | 12.1 | 55.0 | 21.0 |
| 3 | 69 | F | N | PT, RPA, and LPA | III | 76 | 40 | 16.4 | 7.6 | 62.9 | 0.2 |
| 4 | 57 | M | N | PT, RPA, and LPA | III | 68 | 21 | 9.8 | – | – | 1.0 |
| 5 | 40 | M | A | PT | I | 65 | 23 | 7.7 | 14.4 | 57.2 | 16.0 |
| 6 | 69 | M | A | PT and RPA | II | 67 | 39 | 13.8 | 11.2 | 90.8 | 10.0# |
| 7 | 39 | M | A | RPA | II | 73 | 44 | 13.4 | 9.8 | 73.2 | 44.0 |
| 8 | 67 | M | A | PT, RPA, and LPA | IV | 53 | 19 | 11.3 | 7.5 | 50.0 | censored |
| 9 | 44 | F | A | PT, RPA, and LPA | I | 73 | 38 | 6.1 | 17.9 | 60.6 | censored |
| 10 | 52 | M | A | PT, RPA, and LPA | II | 63 | 33 | 10.7 | 23.7 | 142.0 | 11.0# |
| 11 | 27 | F | A | PT and LPA | IV | 72 | 39 | 17.2 | 10.7 | 114.8 | 5.0 |
| 12 | 37 | F | N | PT and RPA | I | 31 | 13 | 3.0 | 5.4 | 10.7 | 15.0 |
| 13 | 47 | M | - | PT and RPA | II | 47 | 24 | 4.0 | 14.9 | 35.1 | 14.0 |
| 14 | 56 | M | A | PT, RPA, and LPA | II | 35 | 15 | 7.0 | 21.8 | 81.0 | 2.0 |
M male, F female, N normal, A abnormal, PT pulmonary trunk, RPA right pulmonary artery, LPA left pulmonary artery, OS overall survival
#To the end of December 2021